Global Health Effects of Osteopenia and Osteoporosis, 1990–2021
Health Science Reports · 2025-10 · 8 (10)
DOI: 10.1002/hsr2.71378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 22.10.2025. Verfasst von Saeid Safiri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Social Determinants of Health Research Center, Department of Community Medicine, Faculty of Medicine Tabriz University of Medical Sciences Tabriz Ira…. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Aims Osteopenia and osteoporosis present a significant global public health challenge. This study analyses the global, regional, and national burden of disease attributable to low bone mineral density, including both osteopenia and osteoporosis, across 204 countries and territories from 1990 to 2021.
Methods
Data were used to quantify deaths and disability‐adjusted life years (DALYs) linked to osteopenia and osteoporosis.
Results
In 2021, osteopenia and osteoporosis were responsible for 459,661 deaths and 17.3 million DALYs globally, with population attributable fractions of 0.7% and 0.6%, respectively. The global age‐standardized death rate was 5.7 per 100,000, while the age‐standardized DALY rate was 205 per 100,000, reflecting declines of 9.4% and 14.8%, respectively, from 1990 to 2021. The highest age‐standardized DALY rates were seen in Saudi Arabia and India, while the lowest were in Azerbaijan and Jamaica. Significant increases in DALY rates were noted in Lesotho and the Netherlands, whereas the largest decreases occurred in Hungary and Taiwan. DALY rates for osteopenia and osteoporosis were highest in the 95+ age group for both sexes, with females generally experiencing higher rates, particularly in older age groups. The main contributing causes varied by age, with falls being the leading cause in the 80–84 age group, road injuries in the 40–44 age group, and exposure to mechanical forces in the 50–54 age group. A negative correlation was observed between regional socio‐demographic index and age‐standardized DALY rates from 1990 to 2021.
Conclusion
Addressing the global burden of osteopenia and osteoporosis requires targeted interventions, further research, and efforts to reduce regional disparities and improve healthcare access.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Social Determinants of Health Research Center, Department of Community Medicine, Faculty of Medicine Tabriz University of Medical Sciences Tabriz Iran.
- Department of Genetics and Bioengineering Yeditepe University İstanbul Turkey.
- Aging Research Institute Tabriz University of Medical Sciences Tabriz Iran.
- Nutrition Research Center, Department of Biochemistry and Diet Therapy, School of Nutrition and Food Sciences Tabriz University of Medical Sciences Tabriz Iran.
- Department of Life and Health Sciences University of Nicosia Nicosia Cyprus.
- Department of Social Sciences University of Nicosia Nicosia Cyprus.
ORCID-Profile: Mohammad Rahmanian, Gary S Collins
Zitieren
APA
Safiri, S., Amiri, F., Karamzad, N., Sullman, M. J. M., Rahmanian, M., Aletaha, R., Mansournia, M. A., Collins, G. S., Şahin, F., & Kolahi, A. A. (2025). Global Health Effects of Osteopenia and Osteoporosis, 1990–2021. Health Science Reports, 8(10). https://doi.org/10.1002/hsr2.71378
Vancouver
Safiri S, Amiri F, Karamzad N, Sullman MJM, Rahmanian M, Aletaha R, et al. Global Health Effects of Osteopenia and Osteoporosis, 1990–2021. Health Science Reports. 2025;8(10). doi:10.1002/hsr2.71378
BibTeX
@article{Safiri2025,
author = {Safiri, Saeid and Amiri, Fatemeh and Karamzad, Nahid and Sullman, Mark J M and Rahmanian, Mohammad and Aletaha, Reza and Mansournia, Mohammad Ali and Collins, Gary S and Şahin, Fikrettin and Kolahi, Ali-Asghar},
title = {Global Health Effects of Osteopenia and Osteoporosis, 1990–2021},
journal = {Health Science Reports},
year = {2025},
volume = {8},
number = {10},
doi = {10.1002/hsr2.71378}
}
EUVIMED